Edward P. Evans Foundation Awards $16 Million for MDS Research
Edward P. Evans Foundation Awards $16 Million for MDS Research
Six research centers will share a five-year, $16 million grant from the Edward P. Evans Foundation to study myelodysplastic syndromes (MDS), a group of diseases that affect the bone marrow and blood, the Boston Business Journal reports.
The six institutions will form a consortium that includes the University of Texas M.D. Anderson Cancer Center in Houston; the Dana-Farber Cancer Institute in Boston; the Cleveland Clinic Taussig Cancer Institute; the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida; Weill Medical College of Cornell University in New York City; and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore. Sponsored by the Aplastic Anemia & MDS International Foundation, the consortium will embark on a five-year project to advance the treatments and outcomes for patients with MDS, which affects some fifteen thousand people in the United States.
"One institution's clinical and research activities typically are not enough to generate, in a timely manner, the research needed to provide a better understanding of MDS," said David Steensma, who will lead the Dana-Farber team. "By working together, however, faculty at the six institutions will collaborate on clinical trials and share clinical and laboratory observations, which will help us to more quickly develop new and better treatments for MDS."
Donnelly, Julie.
“Dana-Farber to Share in $16 Million Rare-Disease Grant.”
Boston Business Journal
7/10/12.
Primary Subject: Health
Secondary Subject(s): Medical Research
Location(s): Baltimore, Boston, Casanova, Cleveland, Florida, Houston, Maryland, Massachusetts, New York, New York City, Ohio, Tampa, Texas, Virginia
FC018031
| 
